Home | Cardiovascular Business

The Farapulse Boston Scientific Pulsed Field Ablation (PFA) system gained U.S. FDA approval in early 2024.

The Boston Scientific Farapulse Pulsed Field Ablation (PFA) system gained U.S. FDA approval in early 2024.

The FDA’s final decision was based largely on positive results from the ADVENT clinical trial, which compared treatment with the Farapulse PFA System to the current standard of care.

Read more about FDA approves Boston Scientific’s pulsed field ablation system for AFib

According to the U.S. government, Asante Health System and one of its surgeons knowingly submitted false claims to Medicare, Medicaid and TRICARE for more than six years. Heart surgery surgeons.

Annual SAVR volumes in the United States decreased by a whopping 44.5% from 2012 to 2022. However, heart teams across the country seem to agree that surgery is a safer, more effective treatment option than TAVR when patients present with bicuspid aortic valves.

Read more about SAVR in the TAVR era: Volumes are down, but it remains the go-to choice for certain patient populations

Jeremy Slivnick, MD, presents at the American Society of Echocardiography (ASE) 2023 meeting on how artificial intelligence (AI) can help make echocardiography better able to detect subtle signs of early cardiac amyloid disease when it is easier to treat with better outcomes. ssistant professor of medicine and an advanced cardiac imager at the University of Chicago. Photo by Dave Fornell

Jeremy Slivnick, MD, University of Chicago, presents at the American Society of Echocardiography (ASE) 2023 meeting on how artificial intelligence (AI) can help make echocardiography better able to detect subtle signs of early cardiac amyloid disease when it is easier to treat. Photo by Dave Fornell

Jeremy Slivnick, MD, spoke with Cardiovascular Business about AI's potential to transform how cardiac amyloidosis is diagnosed and treated.

Read more about AI models for cardiac amyloidosis could make a world of difference

Example of the Esolution device developed by S4 Medical being used during a radiofrequency ablation procedure. Image courtesy of Daoud et al.

Injuries to the esophagus remain a common complication associated with radiofrequency ablation procedures. New research suggests a device developed by S4 Medical could significantly reduce the risk of such injuries.

Read more about New medical device helps cardiologists limit esophageal injuries during RF ablation procedures

U.S. News & World Report children’s hospitals cardiology heart surgery. SCAI said the Accelerating Kids' Access to Care Act would make it easier for children to access pediatric cardiology specialists in neighboring states when none are in their state, or out-of-state doctors are closer.

You can't judge a pediatric heart center by its volume, according to new research presented during STS 2024 in San Antonio.

Read more about Heart surgery outcomes comparable at high- and low-volume children’s hospitals

ACC 2023 ACC.23 American College of Cardiology

The group's annual meeting heads to Atlanta this April. TAVR, GLP-1 agonists, medical imaging guidance and blood pressure control are just some of the topics that will be presented during late-breaking sessions.

Read more about American College of Cardiology announces late-breaking research for ACC.24 in Atlanta

The two neighboring practices have joined forces to provide improved cardiovascular care for patients throughout the Sunshine State.

Read more about Florida cardiology practices unite with help from private equity-backed cardiovascular group

Jennifer C. Romano, MD, MS, is elected president of the Society of Thoracic Surgeons. Image from STS 2024 courtesy of the Society of Thoracic Surgeons.

STS announced the news Monday at its annual meeting in San Antonio. Jennifer C. Romano, MD, MS, is officially the first female president in the organization's 60-year history.

Read more about Congenital heart specialist named first female president of Society of Thoracic Surgeons

Nearly 50% of patients under the age of 60 are now opting for TAVR over SAVR, according to a new study presented at STS 2024 in San Antonio. "We owe it to our patients to take a more prominent role in providing the highest quality evidence to help our patients make these major healthcare decisions," one researcher said.

Read more about Heart surgeons alarmed by high number of young patients choosing TAVR over SAVR

Element Science Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)

The device, which also received Great Britain’s UKCA marking, was specifically designed to be less bulky and easier to wear than other wearable cardioverter-defibrillators.

Read more about New patch-based wearable defibrillator receives CE mark approval